SLPI and acute kidney injury: Compared with patients without AKI after kidney transplantation, there is an increase of secretory leucocyte peptidase inhibitor (SLPI) in AKI patient plasma and urine; SLPI has a unique significance in transplantation-related AKI (13), and in the perfusion solution.